Ananda Pharma (STU:1FX) EV-to-EBITDA : -21.95 (As of May. 16, 2025)

Ananda Pharma EV-to-EBITDA Chart

Ananda Pharma Semi-Annual Data
	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jul24
EV-to-EBITDA	Get a 7-Day Free Trial							-8.26	-	-10.27	-	-

Competitive Comparison of Ananda Pharma's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ananda Pharma's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ananda Pharma's EV-to-EBITDA falls into.

Ananda Pharma EV-to-EBITDA Calculation

Ananda Pharma's EV-to-EBITDA for today is calculated as:

Ananda Pharma's current Enterprise Value is €19.69 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ananda Pharma's EBITDA for the trailing twelve months (TTM) ended in Jul. 2024 was €-0.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma  (STU:1FX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Ananda Pharma's PE Ratio (TTM) for today is calculated as:

Ananda Pharma's share price for today is €0.0025.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ananda Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 was €-0.002.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Ananda Pharma EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Pharma Business Description